Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis

The role of FDG PET-CT in incidental lymphadenopathy

David Brandon, Dacian Bonta, Scott Bartley and Naomi Alazraki
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1450;
David Brandon
1Emory University, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dacian Bonta
1Emory University, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Bartley
1Emory University, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naomi Alazraki
1Emory University, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 53 no. supplement 1 1450

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2012

Author Information

  1. David Brandon1,
  2. Dacian Bonta1,
  3. Scott Bartley1 and
  4. Naomi Alazraki1
  1. 1Emory University, Atlanta, GA

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014100
Jan 2015300
Jun 2015700
Jul 2015300
Aug 2015200
Sep 2015300
Feb 2016300
Mar 2016100
Apr 2016100
Jun 2016100
Aug 2016400
Sep 2016300
Oct 2016800
Nov 2016400
Dec 20161700
Jan 2017600
Feb 2017600
Mar 20171100
Apr 2017800
May 20171200
Jun 2017700
Jul 2017500
Aug 20171300
Sep 20172700
Oct 20172500
Nov 20171800
Dec 20171300
Jan 20182000
Feb 20182100
Mar 20183900
Apr 20183500
May 20183900
Jun 20181500
Sep 20181300
Oct 20181600
Nov 20181100
Dec 20181100
Jan 2019900
Feb 20193200
Mar 20193000
Apr 20192900
May 20195200
Jun 20193500
Jul 20192700
Aug 20195600
Sep 20193400
Oct 20194500
Nov 20196000
Dec 20195800
Jan 20204900
Feb 20206700
Mar 20207200
Apr 20204200
May 20204400
Jun 20208500
Jul 20204300
Aug 20208800
Sep 202010000
Oct 20209900
Nov 20209000
Dec 20208700
Jan 20216900
Feb 202110100
Mar 202110000
Apr 202113400
May 202116500
Jun 202115500
Jul 202115900
Aug 202118300
Sep 202112600
Oct 202114500
Nov 202117400
Dec 202113100
Jan 202215500
Feb 20229900
Mar 202215400
Apr 202211400
May 202210300
Jun 20227700
Jul 20228300
Aug 20227600
Sep 20228800
Oct 20228500
Nov 20229200
Dec 20227400
Jan 202310100
Feb 20239900
Mar 20238000
Apr 20233800
May 20236200
Jun 20235800
Jul 20236100
Aug 20238000
Sep 20235000
Oct 20235500
Nov 20233300
Dec 20235200
Jan 202410000
Feb 20245700
Mar 20245200
Apr 20247000
May 20246700
Jun 20244900
Jul 202411700
Aug 20249700
Sep 202414400
Oct 202414900
Nov 202415600
Dec 202411100
Jan 202512900
Feb 202512200
Mar 202514900
Apr 202515500
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 53, Issue supplement 1
May 2012
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The role of FDG PET-CT in incidental lymphadenopathy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The role of FDG PET-CT in incidental lymphadenopathy
David Brandon, Dacian Bonta, Scott Bartley, Naomi Alazraki
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1450;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The role of FDG PET-CT in incidental lymphadenopathy
David Brandon, Dacian Bonta, Scott Bartley, Naomi Alazraki
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1450;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis

  • Survival Prognostic Value of Morphological and Metabolic variables in Patients with Stage I and II Non-Small Cell Lung Cancer
  • Incremental Value of FDG PET/CT in the Evaluation of Ascites of Malignant Origin with an Unknown Primary
  • Evaluation of the Role of Positron Emission Tomography (PET) in Patients with Suspected Paraneoplastic Syndrome
Show more Oncology: Clinical Diagnosis

MTA I: Other Tumors Posters

  • FDG-PET/CT for the evaluation of non-osseous sites of Langerhans cell histiocytosis
  • Clinical Significance of FDG PET/CT in the Pediatric Neuroblastoma
  • Diagnostic performance of 68Ga-DOTATATE PET/CT over conventional imaging in the evaluation of histopathologically proven cases of extra-adrenal paraganglioma
Show more MTA I: Other Tumors Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire